Krebs Biochemicals & Industries Ltd. benchmarking: Perfomance to industry peers

Financial

	Krebs Biochem.&Inds	Kimia Biosciences	Achyut Healthcare
Operational Metrics
Financials
5 yr Average ROE	37.05 %	-352.38 %	2.92 %
5yr average Equity Multiplier	-2.13	65.1	1.26
5yr Average Asset Turnover Ratio	0.3	1.17	0.52
5yr Avg Net Profit Margin	-55.19 %	-2.03 %	5.17 %
Price to Book	0.0	0.0	4.47
P/E	0.0	16.63	254.9
5yr Avg Cash Conversion Cycle	-1144.52 Days	28.76 Days	15.23 Days
Inventory Days	102.59 Days	94.07 Days	38.82 Days
Days Receivable	8.23 Days	101.18 Days	105.12 Days
Days Payable	623.06 Days	144.79 Days	84.53 Days
5yr Average Interest Coverage Ratio	-4.97	0.28	272.88
5yr Avg ROCE	-23.43 %	-0.98 %	4.18 %
5yr Avg Operating Profit Margin	-34.39 %	1.32 %	-0.85 %
5 yr average Debt to Equity	-1.88	29.7	0.0
5yr CAGR Net Profit	-0.84 %	n/a	122.88 %
5yr Average Return on Assets	-16.47 %	-2.12 %	2.2 %
Shareholdings
Promoter Holding	72.74 %	74.94 %	47.07 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-19.11 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Krebs Biochem.&Inds	Kimia Biosciences	Achyut Healthcare
Product Wise Break-Up	Product Wise Break-Up Phenylephrine 62.86 Simvastatin 13.01 Sabam-RSS 0 Pharmaceuticals 0 Pharmaceutical Products 0 Others 24.13	Product Wise Break-Up Pharmaceutical 100.0 Simvastatin 0 Sabam-RSS 0 Phenylephrine 0 Pharmaceutical Products 0	Product Wise Break-Up Pharmaceuticals 0 Simvastatin 0 Sabam-RSS 0 Phenylephrine 0 Pharmaceutical Products 100.0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0 International 0 Domestic 0	Location Wise Break-Up Rest of the World 0 Domestic 81.72 India 0 International 18.28	Location Wise Break-Up Rest of the World 0 Domestic 0 India 98.72 International 0 Others 1.28
Therapeutic Area Break-Up	Therapeutic Area Break-Up Respiratory Systems 41.0 Cardiac Science 36.0 Others 23.0	-	-